📉 Monday's selloff might be just the start

Coke goes back to 2019 | J&J fumbles an easy pass | [TOGETHER WITH]( Hi {NAME}, here's what you need to know for July 22nd in 3:13 minutes. 🐦 Join us live on [Twitter Spaces]( at 6pm UK time / 1pm NY time on Thursday: one of our analysts will be sharing how to invest in the space race – and whether it will, in fact, take your portfolio to the moon. [Sign up here]( Today's big stories - Coca-Cola posted better-than-expected quarterly earnings thanks to the world's reopening economies - If Monday's stock market selloff got you feeling anxious, there are a few ways to settle your portfolio's jitters – [Read Now]( - Johnson & Johnson reported better-than-expected quarterly earnings, and it’s expecting its vaccine to make big money this year Spin The Bottle [Spin The Bottle] What’s Going On Here? Coca-Cola is done playing coy about what a catch it is: the drinks giant posted quarterly earnings that came in ahead of expectations on Wednesday. What Does This Mean? Wherever there’s a social hotspot – a restaurant, a theater, a stadium – there’s sure to be a tap with “Coca-Cola” emblazoned on it. So with plenty of spots getting well and truly hot again last quarter, the drinks giant’s organic revenue growth – excluding the effects of currency swings and acquisitions – [climbed]( an expectation-busting 37% compared to the same time last year. That strong growth means Coke’s quarterly revenue has now overtaken pre-pandemic levels, and its outlook for the rest of the year looks like it’ll continue that trend: the drinks maker is now expecting to grow organic revenue and profit by up to 14% this year – up from roughly 9% and 10% respectively. Why Should I Care? For markets: Coke’s prices are right. Investors sent Coke’s shares up on Wednesday, but the company’s better-than-expected results mightn’t be the only reason investors have taken a fancy to the stock. With the specter of [inflation]( looming, they’ve been on the lookout for companies that can easily offset the [rising]( costs of raw materials by nudging up their own product prices. And since “consumer staples” sell things that shoppers tend to buy no matter what, they fit the bill exactly. Case in point: Coke said on Wednesday that its prices will have risen as much as 3% between 2019 and 2021. Zooming out: Pepsi had a good run. Arch-rival Pepsi [reported]( better-than-expected results of its own last week, but its 13% organic revenue growth was almost two-thirds lower than Coke’s ([tweet this](). The company, after all, has a big snacks business and sells more of its drinks in grocery stores than Coke does. Both of those benefit much more from a world in limbo, as well as from the crushing existential despair that might push someone to drink a Pepsi in the first place. You might also like: [How to protect your portfolio against rising inflation.]( Copy to share story: [( 🙋 [Ask a question](mailto:questions@finimize.com?body=Ask us a question: Where are you writing from? Let us know and we'll mention it when we reply.&noapp=true&subject=Spin The Bottle&utm_campaign=daily-global-22-07-2021&utm_source=email) 2. Analyst Take How To Settle Your Nerves After Monday’s Selloff What’s Going On Here? It’s been a year of remarkably benign conditions for US stocks, which have gone without a peak-to-trough drawdown of [more than 5%](. But [Monday’s sudden drop of 1.6%]( – its biggest in two months – was a bracing reminder that stocks aren’t guaranteed to keep going up. In fact, a [quick look back through history]( shows how rare such stability is. So if Monday’s pullback has snapped you out of your rose-colored stock market gaze, you might want to start thinking about [a few ways you can fight back](. That’s today’s Insight: [the best ways to strengthen your portfolio in case stock markets turn](. [Read or listen to the Insight here]( SPONSORED BY INVESTENGINE Simple, stress-free investing InvestEngine’s new commission-free [DIY portfolio service]( is a great way to make your money work harder. Here’s how [InvestEngine DIY]( works. First, choose from a range of best-in-class exchange-traded funds (ETFs). They’re all handpicked by [InvestEngine’s expert investment team]( to offer both great value and wide diversification. Second, set the weight of each ETF in your portfolio. You can tweak according to your risk appetite, or put more emphasis on stocks, bonds, or commodities – all in no time with [InvestEngine’s app.]( Third, get investing – and when you need to rebalance, it’ll take just one click: InvestEngine’s technology will [buy and sell ETFs for you]( to bring your portfolio back to its target weighting. InvestEngine even gives you a welcome bonus: [get your £50 bonus here](. [Get Your Bonus]( Disclaimer: Capital at risk. Welcome bonus terms and conditions apply, subject to minimum investment. Investengine (UK) Limited is Authorised and Regulated by the Financial Conduct Authority FRN [801128] No More Tears [No More Tears] What’s Going On Here? Dry your eyes, Johnson & Johnson: the pharmaceutical giant announced better-than-expected quarterly earnings on Wednesday. What Does This Mean? Both Johnson & Johnson’s (J&J’s) revenue and profit beat investors’ expectations, [rising]( 27% and 73% respectively from the same time last year. More than half that revenue growth came from a strong rebound in the company’s medical devices unit, which took a thumping last year as the pandemic forced hospitals to postpone surgeries. J&J’s pharmaceutical segment – the biggest of its businesses – should be getting a boost too: the pharma giant said it was expecting $2.5 billion in sales from its single-shot vaccine in 2021. That’d be a remarkably strong finish to the year given that the vaccine only generated $164 million last quarter, but the company’s gone all in on the estimate: it upped its growth outlook for both its total revenue and profit this year. Why Should I Care? For markets: Repeat after us: cancer bad. Curing coronavirus is both ethically responsible and commercially shrewd, sure, but J&J would do well to remember that giving people cancer isn’t: the company recently had to [recall]( its sunscreens after they were found to be contaminated with a carcinogen. And the last thing J&J needs is another fine, with the company already expected to reach an agreement to [pay]( $5 billion to different US states over its role in the opioid crisis. The bigger picture: Delta’s your captain now. J&J’s anticipated $2.5 billion in sales is a drop in the ocean compared to how much Pfizer and Moderna’s shots – which are in much wider use – are expected to make. And even that revenue stream could be derailed if US production troubles keep hobbling the vaccine’s rollout, or if the highly contagious delta variant – now dominant in many countries around the world – ends up reducing the shot’s effectiveness, as plenty of experts are [worried]( it’ll do. You might also: [How to profit from the vaccine rollout without investing in pharma.](  Copy to share story: [( 🙋 [Ask a question](mailto:questions@finimize.com?body=Ask us a question: Where are you writing from? Let us know and we'll mention it when we reply.&noapp=true&subject=No More Tears&utm_campaign=daily-global-22-07-2021&utm_source=email) 💬 Quote of the day “If you think you can do a thing or think you can’t do a thing, you’re right.” – Henry Ford (an American industrialist and business magnate) [Tweet this]( 🤔 Q&A · [RE: Direct To Investors]( Q: “Why can’t companies pocket the cash from shares sold in a direct listing? Who gets the money if not the company?” – Eric in Massachusetts, USA A: “The main reason is that direct listings work differently to initial public offerings (IPOs). In an IPO, companies sell investors new shares to raise cash. A direct listing, however, puts existing shares onto the stock market. That means investors with previously owned shares can sell them to get cash from new investors, but that the company itself doesn’t raise any money – though that might change in the future.” [Finimize] 🙋 [Ask a question](mailto:questions@finimize.com?body=Ask us a question: Where are you writing from? Let us know and we'll mention it when we reply.&noapp=true&subject=I have a question Finimize!&utm_campaign=daily-global-22-07-2021&utm_source=email) SPONSORED BY NEXO Earn 12% on your crypto and your cash Let’s face it, traditional banks aren’t earning you interest anymore. So it’s a good thing [crypto platforms like Nexo]( are stepping up to the plate. With[Nexo](, you’ll earn up to 12% per year on crypto and your cash. That means you can have your [tokens and your dollars earning interest at a tidy rate]( – both in the same place. The interest you’ll earn [compounds and is paid out daily](, so you’ll reap the benefits without breaking stride. No fees, either. Over a million people are already using Nexo: [get started in seconds](. [Get Started With Nexo]( When you support our sponsors, you support us. Thanks for that. 🎯 On our Radar - Get the right tools for the job. [InvestEngine DIY]( provides a better way to invest for the masses.* - A small step toward big dreams. [Jeff Bezos went to space]( too. - Buying things won’t make you happier. [Buying time might](, though. - It’s been said time and time again. [Crash diets don’t work](: here’s why. - Mmm, armpits. The weird science of [how sweat attracts](. When you support our sponsors, you support us. Thanks for that. 🌎 Finimize Live 🔨 Going, going, gone You might have heard of StockX, the “stock market of things” like sneakers and collectibles. Well, it was a close bid, but we managed to snag StockX’s Derek Morrison for our [How To Invest In Sneakers And Streetwear]( event, so he can help you make money off the most in-demand gear. 👟 [How To Invest In Sneakers And Streetwear](: 1pm UK time, July 22nd 🌿 [How To Invest In The Future Of Cannabis](: 6pm UK time, July 23rd 📈 [How To Protect Yourself From Rising Prices](: 6pm UK time, July 26th 👑 [How To Invest Like The Ultra-Wealthy](: 5pm UK time, July 28th 🌎 [How To Profit From Emerging Markets](: 6pm UK time, July 28th 🏙 [Investing In A Sustainable Metropolis](: 11am UK time, July 29th 💰 [How To Make Money From Money](: 3pm UK time, August 4th 🔥 [How To Invest In The Next Big Thing](: 5pm UK time, August 11th 🤔 [Are You An Investor Or A Trader?](: 12pm UK time, August 25th ♻️ [How To Turn Your Portfolio Green](: 6pm UK time, Sep 23rd ❤️ Share with a friend Your Referrals: 0 Thanks for reading {NAME}. If you liked today's brief, we'd love for you to share it with a friend. If they sign up on your unique link, you’ll earn some sweet swag. Share your unique link: [ You stay classy, {NAME} 😉 We’d love to hear your thoughts. [Give feedback]( Want to advertise with us too? [Get in touch]( Image Credits: Image credits: iTons - Shutterstock | Chastity Cortijo - Unsplash Preferences: [Update your email]( or [change preferences]( [View in browser]( [Unsubscribe]( from all Finimize Emails 😴 Crafted by Finimize Ltd. | Third Floor, 1 New Fetter Lane, London, EC4A 1AN, UK. All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at finimize.com or through one of our partners. © Finimize 2021 [View Online](